Goodwin advised Nuvig Therapeutics on the deal. Nuvig Therapeutics announced its $47 million Series A financing and the launch of the company to develop novel therapeutics that...
Nuvig Therapeutics’ $47 Million Series A Financing
OPKO Health’s Acquisition of ModeX Therapeutics
Goodwin advised ModeX Therapeutics, Inc. on the deal while Greenberg Traurig represented OPKO Health Inc. ModeX Therapeutics, Inc. announced its sale to OPKO Health, Inc. (NASDAQ: OPK)...
PepGen’s $108 Million Initial Public Offering
Latham & Watkins represented the underwriters in the IPO while Goodwin advised PepGen. PepGen, Inc., a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with...
Alan’s €183 Million Fundraising
Goodwin advised Ontario Teachers’ Pension Plan (OTPP) while Orrick represented Alan. Ontario Teachers’ Pension Plan (OTPP) led the $193 million Series E financing round of the French...
GFBiochemicals’ €15 Million Series A Fundraising
Goodwin Procter advised GFBiochemicals on the deal. GFBiochemicals, a leading sustainable chemical company and its founder, Mathieu Flamini, announced its €15 million Series A fundraising. Led by...
TowerBrook Capital Partners’ Acquisition of Premium Credit from Cinven
Freshfields Bruckhaus Deringer advised international private equity firm Cinven on the deal. Travers Smith LLP advised the management team of Premium Credit. Goodwin represented TowerBrook Capital...
Ontario Teachers’ Pension Plan’s Investment in VerSe Innovation
Goodwin advised Ontario Teachers’ Pension Plan on the deal. Ontario Teachers’ Pension Plan announced its investment in VerSe Innovation as part of VerSe Innovation’s US$ 805 million...
Signicat’s Acquisition of Sphonic
Goodwin Procter advised Sphonic on the deal. Sphonic and its shareholders announced the sale of all of its shares to Signicat. Sphonic is a London-based RegTech business, established...
Checkr’s Acquisition of GoodHire
Goodwin advised Checkr on the deal. Checkr announced its acquisition of GoodHire. Checkr, founded in 2014, provides either online access or an API that returns automatically generated...
Packfleet’s £8 Million Seed Funding Round
Goodwin advised Creandum on the deal. Creandum announced an £8 million seed funding round into Packfleet. Packfleet is the provider of logistics technology which is used...
Tessera Therapeutics’ $300 Million Series C Financing
Goodwin advised Tessera Therapeutics on the deal. Tessera Therapeutics announced its Series C financing, which totaled over $300 million. Tessera is a biotechnology company pioneering a...
Regeneron Pharmaceuticals’ Acquisition of Checkmate Pharmaceuticals
Wachtell, Lipton, Rosen & Katz advised Regeneron on the deal, while Goodwin represented Checkmate Pharmaceuticals. Fried Frank acted as counsel to Centerview Partners, financial advisor to...